VoxNeuro is a Software as a Medical Device (SaMD) brain health company that analyzes brain-based biomarkers to assess cognitive function.
We are pushing the boundaries of brain health and empowering physicians with a breakthrough technology that delivers a comprehensive understanding of how a brain is functioning by measuring attention and concentration, information processing, and working memory.
Our technology is based on thorough research, with more than 300 peer-reviewed publications on EEG, including numerous breakthrough findings, published by Chief Science Officer John F. Connolly, PhD, since 1982. VoxNeuro's research and innovation is a constant, and our technology will continue to advance the way brain health is managed.
Learn more at voxneuro.com
Location: Canada, Ontario, Hamilton
Member count: 11-50
Total raised: $3.4M
Founded date: 2017
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 04.08.2023 | - | $3.4M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 04.08.2023 | VoxNeuro raises $4.5 million CAD to scale brain performance ... | - | betakit.co... |
| 03.08.2023 | VoxNeuro Raises $3.4M in Funding | VoxNeuro Inc., a Boston, MA-based company that develops EEG-based brain performance software, closed... | finsmes.co... |
| - | VoxNeuro | “VoxNeuro empowers clinical decision making by measuring brain-based biomarkers to provide a holisti... | fastfounde... |